Expression of the Human Parvovirus B19 Protein Fused to Protein A in Escherichia coli: Recognition By IgM and IgG Antibodies in Human Sera

References

1. Anand A., Gray E. S., Brown T., Clewley J. P., Cohen B. J. 1987; Human parvovirus infection in pregnancy and hydrops fetalis. New England Journal of Medicine 316:183–186
   [Google Scholar]
2. Anderson M. J., Lewis E., Kidds I. M., Hall S. M., Cohen B. I. 1984; An outbreak of erythema infectiosum associated with human parvovirus infection. Journal of Hygiene 93:85–93
   [Google Scholar]
3. Blundell M. C., Beard C., Astell C. R. 1987; In vitro identification of a B19 parvovirus promoter. Virology 157:534–538
   [Google Scholar]
4. Brown T. A., Anand A., Ritchie L. D., Clewley J. P., Reid M. S. 1984; Intrauterine parvovirus infection associated with hydrops fetalis. Lancet ii:1033–1034
   [Google Scholar]
5. Clewley J. P. 1984; Biochemical characterization of a human parvovirus. Journal of General Virology 65:241–245
   [Google Scholar]
6. Cossart Y. E., Cant B., Field A. M., Widdows D. 1975; Parvovirus-like particles in human serum. Lancet i72–73
   [Google Scholar]
7. Cotmore S. F., Tattersall P. 1984; Characterization and molecular cloning of a human parvovirus genome. Science 226:1161–1165
   [Google Scholar]
8. Cotmore S. F., Mckle V. C., Anderson M. J., Astell C. R., Tattersall P. 1986; Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. Journal of Virology 60:548–557
   [Google Scholar]
9. Holmes D. S., Quigley M. 1981; A rapid boiling method for the preparation of bacterial plasmids. Analytical Biochemistry 114:193–195
   [Google Scholar]
10. Kurtzman G. J., Ozawa K., Cohen B. J., Hanson G., Oseas R., Young N. S. 1987; Chronic bone marrow failure due to persistent B19 parvovirus infection. New England Journal of Medicine 317:287–294
    [Google Scholar]
11. Lefrere J. J., Courouce A. M., Muller J. Y., Clark M., Soulier J. P. 1985; Human parvovirus and purpura. Lancet ii730
    [Google Scholar]
12. Morinet F., Tratschin J. D., Perol Y., Siegl G. 1986; Comparison of 17 isolates for the human parvovirus B19 by restriction enzyme analysis. Brief Report. Archives of Virology 90:165–172
    [Google Scholar]
13. Morinet F., Monsuez J. J., Roge P., Perol Y. 1987; Parvovirus B19 associated with pseudoappendicitis. Lancet ii1466
    [Google Scholar]
14. Morrison D. A. 1979; Transformation and preservation of competent bacterial cells by freezing. Methods in Enzymology 68:326–331
    [Google Scholar]
15. Mortimer P. P., Humphries R. K., Moore J. G., Purcell R. H., Young N. S. 1983; A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature London: 302426–429
    [Google Scholar]
16. Nilsson B., Abrahmsen L., Uhlen M. 1985; Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors. EM BO Journal 4:1075–1080
    [Google Scholar]
17. Ozawa K., Young N. 1987; Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. Journal of Virology 61:2627–2630
    [Google Scholar]
18. Ozawa K., Kurtzman G., Young N. 1986; Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233:883–886
    [Google Scholar]
19. Ozawa K., Ayub J., Yu-shu H., Kurtzman G., Shimada T., Young N. 1987; Novel transcription map for the B19 (human) pathogenic parvovirus. Journal of Virology 61:2395–2406
    [Google Scholar]
20. Pattison J. R., Jones S. E., Hodgson J., Davis L. R., White J. M., Stroud C. E., Murtaza L. 1981; Parvovirus infections and hypoplastic crisis in sickle cell anaemia. Lancet i664–665
    [Google Scholar]
21. Reid D. M., Brown T., Reid T. M. S., Rennie J. A. N., Eastmond C. J. 1985; Human parvovirus associated arthritis, a clinical and laboratory description. Lancet i422–425
    [Google Scholar]
22. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of SciencesU.S.A 745463–5467
    [Google Scholar]
23. Shade R. O., Blundell M. C., Cotmore S. F., Tattersall P., Astell C. R. 1986; Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during an aplastic crisis. Journal of Virology 58:921–936
    [Google Scholar]
24. Shneerson J. M., Mortimer P. P., Vandervelde E. M. 1980; Febrile illness due to parvovirus. British Medical Journal i1580
    [Google Scholar]
25. Sisk W. P., Berman M. L. 1987; Expression of human parvovirus B19 structural protein in coli and detection of antiviral antibodies in human serum. Bio/Technology 5:1077–1080
    [Google Scholar]
26. Summers J., Jones S. E., Anderson M. J. 1983; Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus. Journal of General Virology 64:2527–2532
    [Google Scholar]
27. White D. G., Woolf A. D., Mortimer P. P., Cohen B. J., Blake D. R., Bacon P. A. 1985; Human parvovirus arthropathy. Lancet i419–422
    [Google Scholar]
28. Young N. S., Harrison M., Moore J., Mortimer P. P., Humphries R. K. 1984; Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. Journal of Clinical Investigation 74:2024–2032
    [Google Scholar]
29. Zabeau M., Stanley K. K. 1982; Enhanced expression of cro-β-galactosidase fusion proteins under the control of the P_R promoter of bacteriophage. EMBO Journal 1:1217–1224
    [Google Scholar]